TY - JOUR
T1 - Cardiovascular Disease Prevention During the COVID-19 Pandemic
T2 - Lessons Learned and Future Opportunities
AU - Duffy, Eamon
AU - Chilazi, Michael
AU - Cainzos-Achirica, Miguel
AU - Michos, Erin D.
N1 - Publisher Copyright:
Copyright: © 2021 The Author(s).
PY - 2021
Y1 - 2021
N2 - The coronavirus disease 2019 (COVID-19) pandemic has been the defining healthcare issue since its outbreak, consuming healthcare systems and disrupting all aspects of human life throughout 2020 and continuing through 2021. When reviewing cardiovascular disease (CVD) prevention throughout the COVID-19 pandemic, the first tendency may be to focus on the negative disruption. Months of quarantine, isolation, and missed healthcare visits or delayed care may have exacerbated the epidemic of CVD in the United States. Looking back, however, perhaps it wasn't a lost year as much as a health crisis that better prepared us for the battle to improve cardiovascular health. The pandemic brought new platforms for interacting with patients eager to engage, presenting a unique opportunity to reset how we approach preventive care. In this review, we discuss what the pandemic has taught us about caring for those vulnerable patients who were most afflicted-older adults, persons of color, and people facing adverse socioeconomic circumstances-and who continue to be impacted by CVD. We also identify opportunities for enhanced CVD prevention now boosted by the overnight adoption of telemedicine and other innovative cardiac care models. Lastly, we discuss how the COVID-19 pandemic has motivated physicians and patients alike to prioritize our health above all else, if only transiently, and how we can leverage this increased health awareness and investment into long-term, meaningful disease prevention.
AB - The coronavirus disease 2019 (COVID-19) pandemic has been the defining healthcare issue since its outbreak, consuming healthcare systems and disrupting all aspects of human life throughout 2020 and continuing through 2021. When reviewing cardiovascular disease (CVD) prevention throughout the COVID-19 pandemic, the first tendency may be to focus on the negative disruption. Months of quarantine, isolation, and missed healthcare visits or delayed care may have exacerbated the epidemic of CVD in the United States. Looking back, however, perhaps it wasn't a lost year as much as a health crisis that better prepared us for the battle to improve cardiovascular health. The pandemic brought new platforms for interacting with patients eager to engage, presenting a unique opportunity to reset how we approach preventive care. In this review, we discuss what the pandemic has taught us about caring for those vulnerable patients who were most afflicted-older adults, persons of color, and people facing adverse socioeconomic circumstances-and who continue to be impacted by CVD. We also identify opportunities for enhanced CVD prevention now boosted by the overnight adoption of telemedicine and other innovative cardiac care models. Lastly, we discuss how the COVID-19 pandemic has motivated physicians and patients alike to prioritize our health above all else, if only transiently, and how we can leverage this increased health awareness and investment into long-term, meaningful disease prevention.
KW - Aged
KW - COVID-19
KW - Cardiovascular Diseases/diagnosis
KW - Delivery of Health Care
KW - Humans
KW - Pandemics/prevention & control
KW - SARS-CoV-2
KW - Telemedicine
KW - United States/epidemiology
UR - http://www.scopus.com/inward/record.url?scp=85122488070&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85122488070&partnerID=8YFLogxK
U2 - 10.14797/mdcvj.210
DO - 10.14797/mdcvj.210
M3 - Review article
C2 - 34824683
SN - 1947-6094
VL - 17
SP - 68
EP - 78
JO - Methodist DeBakey cardiovascular journal
JF - Methodist DeBakey cardiovascular journal
IS - 4
ER -